1 completed, 1 recruiting. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Follicle Development: new trials by email Literature Review of Follicle Development trials Research Report on Follicle Development
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis Denosumab, PBS - Female Infertility, NF-κB Ligand | Not applicable | Recruiting | Peter Humaidan | 100 | 2025-08-01 | 2026-04-22 |
| A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives Desogestrel/ethinyl estradiol and ethinyl estradiol, 28-day drospirenone oral contraceptive, 28-day levonorgestrel oral contraceptive - Follicle Development, Ovarian Follicle | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 206 | 2011-01-31 | 2021-12-08 |
Infertility, Female (1) · Osteoporosis (1)
Bone Diseases (1) · Bone Diseases, Metabolic (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Infertility (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1) · Urogenital Diseases (1)
Denosumab (1) · Desogestrel (1) · Ethinyl Estradiol (1)
Peter Humaidan (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
Denmark (1) · United States (1)